Vinva Investment Management Ltd Grows Stock Holdings in CME Group Inc. (NASDAQ:CME)

Vinva Investment Management Ltd raised its position in shares of CME Group Inc. (NASDAQ:CME) by 10.0% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 16,526 shares of the financial services provider’s stock after buying an additional 1,509 shares during the period. Vinva Investment Management Ltd’s holdings in CME Group were worth $3,608,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Truvestments Capital LLC acquired a new position in shares of CME Group during the third quarter valued at about $26,000. Y.D. More Investments Ltd acquired a new position in shares of CME Group during the second quarter valued at about $36,000. McClarren Financial Advisors Inc. increased its holdings in shares of CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares in the last quarter. Asset Dedication LLC increased its holdings in shares of CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Price Performance

Shares of NASDAQ CME opened at $237.33 on Friday. The stock has a market capitalization of $85.52 billion, a price-to-earnings ratio of 24.96, a PEG ratio of 5.29 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $238.12. The firm’s 50 day simple moving average is $225.05 and its 200-day simple moving average is $211.73. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the company earned $2.25 EPS. The business’s revenue was up 18.4% on a year-over-year basis. Analysts expect that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.94%. CME Group’s dividend payout ratio (DPR) is 48.37%.

Analyst Ratings Changes

CME has been the topic of several recent analyst reports. Bank of America upped their price objective on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. The Goldman Sachs Group increased their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target on the stock. in a report on Tuesday, October 8th. Morgan Stanley increased their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Finally, Oppenheimer increased their price target on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $224.47.

Insider Activity

In other CME Group news, Director Timothy S. Bitsberger sold 1,000 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the transaction, the director now owns 10,589 shares in the company, valued at approximately $2,403,279.44. This trade represents a 8.63 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 5.38 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,028 shares of company stock worth $1,811,681 in the last quarter. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.